Emergent Discovery – From Scientific Leaps to Breakthrough Medicines
Noubar Afeyan PhD ’87
CEO, Flagship Pioneering
Friday, May 6, 2022
Rm 32-123
3:30 p.m.
3:00 p.m. Reception
Dr. Noubar Afeyan is the founder and CEO of Flagship Pioneering, a company that conceives, creates, resources, and develops first-incategory bioplatform companies to transform human health and sustainability. An entrepreneur and biochemical engineer, Dr. Afeyan holds more than 100 patents and has co-founded and helped build more than 70 life science and technology startups during his 33-year career. He is co-founder and chairman of the board of Moderna, Omega Therapeutics, Generate Biomedicines, Tessera Therapeutics, and Laronde. He is also co-founder and board member of Rubius Therapeutics and YourBio Health.
Dr. Afeyan is a member of the Corporation of MIT (the Institute’s governing body) and a member of the board of trustees for the Boston Symphony Orchestra. Together with his partners, Noubar has launched and supported philanthropic projects including the IDeA Foundation, UWC Dilijan School, FAST, and the Aurora Prize for Awakening Humanity to raise awareness of the world’s most pressing humanitarian problems. Previously, he was a co-founder and board member of the National Competitiveness Foundation of Armenia, a private-public partnership dedicated to promoting economic development in the former Soviet Republic of Armenia.